Europe (WHO region) vs Iraq: New cases tested for RR-/MDR-TB
Europe (WHO region)
88.0%
in 2024
Iraq
100.0%
in 2024
Europe (WHO region) rank
3rd
Iraq rank
1st
New cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Iraq
How they compare
Iraq currently reports 100.0% against 88.0% in Europe (WHO region), a difference of 12.0%.
That makes Iraq's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 5 times across 17 shared years of data; in 2007 it was Europe (WHO region) ahead.
Europe (WHO region) ranks 3rd and Iraq ranks 1st of 11 groups.
Europe (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 59.3% | 0.0% | 59.3% | Europe (WHO region) |
| 2010s | 86.6% | 58.0% | 28.5% | Europe (WHO region) |
| 2020s | 90.8% | 63.1% | 27.7% | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Europe (WHO region) or Iraq?
- Iraq, at 100.0% against 88.0% in Europe (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Europe (WHO region) and Iraq?
- 12.0%, with Iraq ahead.
- How many years of comparable data are there for Europe (WHO region) and Iraq?
- 17 years are reported by both, from 2007 to 2024.
- How do Europe (WHO region) and Iraq rank globally for new cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 3rd and Iraq ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.